Literature DB >> 2430084

Treatment of acute idiopathic thrombocytopenic purpura of childhood with intravenous immunoglobulin G: comparative efficacy of 7S and 5S preparations.

S E Burdach, K G Evers, R G Geursen.   

Abstract

A prospective randomized study comparing 7S immunoglobulin G to a 5S IgG preparation for therapy of acute idiopathic thrombocytopenic purpura was conducted. The 5S preparation differed from the 7S preparation in that it lacked part of the Fc portion of the IgG molecule. Both groups were given 400 mg IgG/kg body weight over 5 days. All patients had platelet counts less than or equal to 30 X 10(9)/L before IgG infusion. Nine of the 10 patients in the 7S treatment group, compared with three of 10 patients in the 5S treatment group, responded to therapy with an increment in platelet counts greater than 100 X 10(9)/L within 4 days of completing the infusion treatment. Furthermore, the rate of increase of the platelets was more rapid in the 7S group. The results emphasize the efficacy of partial Fc for management of acute idiopathic thrombocytopenic purpura.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430084     DOI: 10.1016/s0022-3476(86)80691-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Post-transfusion purpura as the main manifestation of a trilineal transfusion reaction, responsive to steroids: flow-cytometric investigation of granulocyte and platelet antibodies.

Authors:  N Puig; M J Sayas; J A Montoro; J V Villalba; A Pla
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

2.  Fc receptors in immune thrombocytopenias: a target for immunomodulation?

Authors:  Bethan Psaila; James B Bussel
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

Review 3.  Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?

Authors:  Sietse Q Nagelkerke; Taco W Kuijpers
Journal:  Front Immunol       Date:  2015-01-21       Impact factor: 7.561

Review 4.  Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye.

Authors:  Angela S W Tjon; Rogier van Gent; Teunis B Geijtenbeek; Jaap Kwekkeboom
Journal:  Front Immunol       Date:  2015-04-28       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.